dr. nathan on 5-year survival outcomes of combi-d and combi-v trials in braf v600-mutant melanoma
Published 4 years ago • 722 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
1:26
dr. nathan on long-term outcomes with dabrafenib/trametinib in braf v600-mutant melanoma
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
1:40
dr. robert on the phase iii combi-v study in braf-mutant melanoma
-
1:52
dr. long on dabrafenib/trametinib in braf v600e-mutant melanoma
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
-
1:17
dr. dummer on combi-ad trial results in braf-mutant melanoma
-
4:45
combi-ad trial: adjuvant dabrafenib plus trametinib in patients with resected stage iii braf v60...
-
2:12
phase iii combi-d study of dabrafenib and trametinib in patients with melanoma
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
1:04
dr. wilson on long-term data with dabrafenib plus trametinib in melanoma
-
1:03
five-year os data for dabrafenib/trametinib combo in melanoma
-
3:06
combi-d: phase 3 trial of dabrafenib plus trametinib in braf v600e/k-mutated melanoma
-
4:12
adjuvant therapy in melanoma: combi-ad trial
-
4:08
updates from combi-ad: dabrafenib and trametinib for melanoma
-
2:11
dr. georgina long on dabrafenib and trametinib in braf-mutated melanoma
-
1:11
dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma
-
3:05
dabrafenib and trametinib: a promising combination for the treatment of melanoma
-
4:46
5-year survival outcomes from the pacific trial